Skin Substitutes

How skin substitutes works

Healix360 supports access to advanced mobile wound care services for patients throughout our coverage area. Services are delivered by licensed physicians and nurse practitioners experienced in the evaluation and management of chronic and complex wounds. Care is coordinated and provided directly to patients in private residences, assisted living communities, and skilled nursing facilities. Skin substitutes work by altering the biology of a chronic wound. Rather than just covering the defect, these products deliver a massive influx of structural proteins (like collagen and fibronectin), cytokines, and growth factors directly into the wound bed. This biological matrix acts as a scaffold, commanding the patient's own dormant cells to migrate, proliferate, and rapidly regenerate new tissue to close the wound.

When it may be used

A licensed clinician determines whether this treatment is appropriate after evaluating the wound and the patient's medical history.

• Diabetic foot ulcers that have failed to respond to standard care after 30 days.
• Venous leg ulcers stalled in the inflammatory phase.
• Deep traumatic wounds or surgical dehiscence.
• Severe burn wounds requiring immediate coverage to prevent fluid loss.

When it may not be appropriate

Treatment decisions are individualized. Potential contraindications and precautions may include:

• Wounds with active, uncontrolled clinical infection or heavy bioburden.
• Wounds lacking adequate blood supply (severe ischemia without revascularization).
• Known hypersensitivity to the specific biological components (e.g., bovine or porcine allergies for xenografts).

What to expect

The procedure is performed entirely at the bedside. First, your clinician will meticulously debride the wound to ensure a perfectly clean, bleeding base. The skin substitute—often resembling a thin, translucent piece of tissue—is then precisely cut, placed directly onto the wound, and secured with specialized secondary dressings. You will be instructed to keep the area completely dry and offloaded for a specified period to allow the graft to 'take.'

Evidence and clinical context

Extensive peer-reviewed literature and Medicare coverage guidelines support the efficacy of skin substitutes. Clinical trials consistently demonstrate that utilizing CTPs on chronic diabetic and venous ulcers significantly increases the percentage of complete wound closure within 12 weeks compared to standard care.

Frequently Asked Questions

Is a skin substitute the same as a skin graft?

A traditional skin graft involves surgically removing a piece of your own skin (donor site) to cover the wound. A skin substitute is a bioengineered product applied without the need for a painful secondary surgical site on your body.

Are these products made from human tissue?

Some are. Many highly effective products are derived from ethically donated, fully sterilized human placental or amniotic tissue. Others are bioengineered from animal collagen (porcine or bovine) or synthetic materials. Your clinician will select the most appropriate type.

Does the application hurt?

The application of the skin substitute itself is completely painless. However, the necessary sharp debridement performed immediately prior to application may cause brief, manageable discomfort.

How many applications will I need?

This depends on the size and chronicity of the wound, as well as Medicare guidelines. Some wounds require a single application, while chronic ulcers may require weekly applications for several weeks to achieve full closure.

Are skin substitutes covered by insurance?

Yes, when medical necessity criteria are met (usually after a wound has failed 30 days of standard care), the application of cellular and tissue-based products by a licensed clinician is typically covered by Medicare Part B and most commercial insurances.